CRN-I’s third scientific symposium Schlosshotel Kronberg, Kronberg, Germany convenient to CCNFDU meeting

Following up on two previous CRN-I scientific symposia held in 2010 and 2011 which addressed the two primary goals of the Codex Alimentarius and nutrition issues including health claims, respectively, the 2012 symposium explored the scientific basis and approaches for setting nutrient reference values for non-essential nutrients with biological effects—bioactives—with a focus on omega-3 fatty acids, lutein and zeaxanthin.

Click on speaker names for bios, available presentations are linked following speaker name and affiliation, or click here for a ZIP folder containing all available presentations from this symposium.

AGENDA

Program in English

08:00
Registration

08:50
Opening remarks
John Venardos
Chairman, CRN-International
Herbalife Ltd., Torrance, California, USA

09:00
Keynote

The IOM DRI framework and definitions—adaption for bioactives
John W. Erdman, Jr., Ph.D.
University of Illinois at Urbana-Champaign, Illinois, USA

CLICK HERE FOR PRESENTATION (PDF)

Session 1: Approaches to quantitative values for non-essential substances (bioactives)

Session Chair:
John W. Erdman, Jr., Ph.D.

09:45
Data types: Intervention and epidemiology—data to support NRVs
Prof. Dr. Hans Konrad Biesalski
University of Hohenheim, Stuttgart, Germany

CLICK HERE FOR PRESENTATION (PDF)

10:25
Dietary intake patterns for healthy persons to identify Adequate Intake values?
Kathleen Ellwood, Ph.D.
College of Southern Maryland, La Plata, Maryland, USA

CLICK HERE FOR PRESENTATION (PDF)

11:05 Break

Session 2: Lutein and zeaxanthin

Session Chair:
Prof. Stephen Beatty, M.D.

11:35
Impact of supplemental lutein, zeaxanthin and meso-zeaxanthin on visual performance and eye health
Prof. Stephen Beatty, M.D.
Waterford Institute of Technology, Waterford, Ireland

CLICK HERE FOR PRESENTATION (PDF)

12:15
Beyond eye health: Other effects of lutein and zeaxanthin
Elizabeth Johnson, Ph.D.
Tufts University, Boston, Massachusetts, USA

CLICK HERE FOR PRESENTATION (PDF)

12:55 Lunch

Session 3: Omega-3 fatty acids: EPA and DHA

Session Chair:
Roberto Marchioli, M.D., M.P.H., F.A.F.A.

14:00
Health benefits of omega-3 fatty acids
Roberto Marchioli, M.D., M.P.H., F.A.F.A.
Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy

CLICK HERE FOR PRESENTATION (PDF)

14:40
Quantitative needs for omega-3 fatty acids to achieve benefits
Lotte Lauritzen, Ph.D.
University of Copenhagen, Copenhagen, Denmark

CLICK HERE FOR PRESENTATION (PDF)

15:20 Break

Session 4: Safety considerations

15:40
Safety considerations in establishing NRVs for omega-3 fatty acids
Harry B. Rice, Ph.D.
Global Organization for EPA and DHA Omega-3s, Salt Lake City, Utah, USA

CLICK HERE FOR PRESENTATION (PDF)

16:20
Use of risk assessment in the establishment of NRVs
Andrew Shao, Ph.D.
Herbalife Ltd., Torrance, California, USA
Chair, IADSA Scientific Council, Brussels, Belgium

CLICK HERE FOR PRESENTATION (PDF)

17:00
Closing remarks
Mark LeDoux
CRN International
Natural Alternatives, International, Inc., San Marcos, California, USA